NCT01045707View on ClinicalTrials.gov

Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

530

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

insulin degludec/insulin aspart

Injected s.c. (under the skin) once daily with the breakfast meal. Dose was individually adjusted.

DRUG

insulin glargine

Injected s.c. (under the skin) once daily. Dose was individually adjusted.

Trial Locations (92)

1030

Novo Nordisk Investigational Site, Vienna

1060

Novo Nordisk Investigational Site, Vienna

2483

Novo Nordisk Investigational Site, Ebreichsdorf

5010

Novo Nordisk Investigational Site, Salzburg

6020

Novo Nordisk Investigational Site, Innsbruck

8330

Novo Nordisk Investigational Site, Feldbach

11203

Novo Nordisk Investigational Site, Brooklyn

11787

Novo Nordisk Investigational Site, Smithtown

15706

Novo Nordisk Investigational Site, Santiago de Compostela

23606

Novo Nordisk Investigational Site, Newport News

27408

Novo Nordisk Investigational Site, Greensboro

27834

Novo Nordisk Investigational Site, Greenville

27893

Novo Nordisk Investigational Site, Wilson

28223

Novo Nordisk Investigational Site, Pozuelo de Alarcón

28557

Novo Nordisk Investigational Site, Morehead City

28700

Novo Nordisk Investigational Site, San Sebastián de los Reyes

29006

Novo Nordisk Investigational Site, Málaga

29651

Novo Nordisk Investigational Site, Greer

33027

Novo Nordisk Investigational Site, Pembroke Pines

33135

Novo Nordisk Investigational Site, Miami

33136

Novo Nordisk Investigational Site, Miami

33161

Novo Nordisk Investigational Site, North Miami

33169

Novo Nordisk Investigational Site, Miami

34096

Novo Nordisk Investigational Site, Istanbul

34390

Novo Nordisk Investigational Site, Istanbul

34400

Novo Nordisk Investigational Site, Istanbul

34760

Novo Nordisk Investigational Site, Istanbul

35209

Novo Nordisk Investigational Site, Vestavia Hills

35233

Novo Nordisk Investigational Site, Birmingham

37404

Novo Nordisk Investigational Site, Chattanooga

38119

Novo Nordisk Investigational Site, Memphis

41009

Novo Nordisk Investigational Site, Seville

46014

Novo Nordisk Investigational Site, Valencia

47005

Novo Nordisk Investigational Site, Valladolid

48235

Novo Nordisk Investigational Site, Detroit

51501

Novo Nordisk Investigational Site, Council Bluffs

63303

Novo Nordisk Investigational Site, Saint Charles

65807

Novo Nordisk Investigational Site, Springfield

70119

Novo Nordisk Investigational Site, New Orleans

74104

Novo Nordisk Investigational Site, Tulsa

75230

Novo Nordisk Investigational Site, Dallas

75235

Novo Nordisk Investigational Site, Dallas

77375

Novo Nordisk Investigational Site, Tomball

78240

Novo Nordisk Investigational Site, San Antonio

79423

Novo Nordisk Investigational Site, Lubbock

84790

Novo Nordisk Investigational Site, St. George

90057

Novo Nordisk Investigational Site, Los Angeles

94904

Novo Nordisk Investigational Site, Greenbrae

96813

Novo Nordisk Investigational Site, Honolulu

96814

Novo Nordisk Investigational Site, Honolulu

97220

Novo Nordisk Investigational Site, Portland

97239

Novo Nordisk Investigational Site, Portland

98502

Novo Nordisk Investigational Site, Olympia

117036

Novo Nordisk Investigational Site, Moscow

150003

Novo Nordisk Investigational Site, Yaroslavl

163045

Novo Nordisk Investigational Site, Arkhangelsk

214019

Novo Nordisk Investigational Site, Smolensk

302006

Novo Nordisk Investigational Site, Jaipur

355017

Novo Nordisk Investigational Site, Stavropol

400053

Novo Nordisk Investigational Site, Mumbai

410053

Novo Nordisk Investigational Site, Saratov

410710

Novo Nordisk Investigational Site, Saratov

443067

Novo Nordisk Investigational Site, Samara

460040

Novo Nordisk Investigational Site, Orenburg

560038

Novo Nordisk Investigational Site, Bangalore

603126

Novo Nordisk Investigational Site, Nizhny Novgorod

620018

Novo Nordisk Investigational Site, Trichy

682026

Novo Nordisk Investigational Site, Kerala

800020

Novo Nordisk Investigational Site, Patna

94520-1926

Novo Nordisk Investigational Site, Concord

06708

Novo Nordisk Investigational Site, Waterbury

83404-7596

Novo Nordisk Investigational Site, Idaho Falls

70006-2930

Novo Nordisk Investigational Site, Metairie

48085-5524

Novo Nordisk Investigational Site, Troy

31-261

Novo Nordisk Investigational Site, Krakow

90-003

Novo Nordisk Investigational Site, Lodz

93-338

Novo Nordisk Investigational Site, Lodz

20-044

Novo Nordisk Investigational Site, Lublin

05-800

Novo Nordisk Investigational Site, Pruszków

02-507

Novo Nordisk Investigational Site, Warsaw

00961

Novo Nordisk Investigational Site, Bayamón

424-017

Novo Nordisk Investigational Site, Pucheon

602-739

Novo Nordisk Investigational Site, Pusan

08308

Novo Nordisk Investigational Site, Seoul

137-701

Novo Nordisk Investigational Site, Seoul

158-710

Novo Nordisk Investigational Site, Seoul

08035

Novo Nordisk Investigational Site, Barcelona

06800

Novo Nordisk Investigational Site, Mérida

07198

Novo Nordisk Investigational Site, Palma de Mallorca

03114

Novo Nordisk Investigational Site, Partida de Bacarot

07058

Novo Nordisk Investigational Site, Antalya

Unknown

Novo Nordisk Investigational Site, Istanbul

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01045707 - Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes | Biotech Hunter | Biotech Hunter